These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 32254487)
1. pH-Activated nanoparticles with targeting for the treatment of oral plaque biofilm. Zhou Z; Hu F; Hu S; Kong M; Feng C; Liu Y; Cheng X; Ji Q; Chen X J Mater Chem B; 2018 Jan; 6(4):586-592. PubMed ID: 32254487 [TBL] [Abstract][Full Text] [Related]
2. A novel pH-responsive quaternary ammonium chitosan-liposome nanoparticles for periodontal treatment. Hu F; Zhou Z; Xu Q; Fan C; Wang L; Ren H; Xu S; Ji Q; Chen X Int J Biol Macromol; 2019 May; 129():1113-1119. PubMed ID: 30218737 [TBL] [Abstract][Full Text] [Related]
3. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. Horev B; Klein MI; Hwang G; Li Y; Kim D; Koo H; Benoit DS ACS Nano; 2015 Mar; 9(3):2390-404. PubMed ID: 25661192 [TBL] [Abstract][Full Text] [Related]
4. Surface-Adaptive, Antimicrobially Loaded, Micellar Nanocarriers with Enhanced Penetration and Killing Efficiency in Staphylococcal Biofilms. Liu Y; Busscher HJ; Zhao B; Li Y; Zhang Z; van der Mei HC; Ren Y; Shi L ACS Nano; 2016 Apr; 10(4):4779-89. PubMed ID: 26998731 [TBL] [Abstract][Full Text] [Related]
5. Nanocarriers with conjugated antimicrobials to eradicate pathogenic biofilms evaluated in murine in vivo and human ex vivo infection models. Liu Y; Ren Y; Li Y; Su L; Zhang Y; Huang F; Liu J; Liu J; van Kooten TG; An Y; Shi L; van der Mei HC; Busscher HJ Acta Biomater; 2018 Oct; 79():331-343. PubMed ID: 30172935 [TBL] [Abstract][Full Text] [Related]
6. pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells. Luesakul U; Puthong S; Neamati N; Muangsin N Carbohydr Polym; 2018 Feb; 181():841-850. PubMed ID: 29254044 [TBL] [Abstract][Full Text] [Related]
7. Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery. Sims KR; Liu Y; Hwang G; Jung HI; Koo H; Benoit DSW Nanoscale; 2018 Dec; 11(1):219-236. PubMed ID: 30525159 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery. Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060 [TBL] [Abstract][Full Text] [Related]
9. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
10. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700 [TBL] [Abstract][Full Text] [Related]
11. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery. Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154 [TBL] [Abstract][Full Text] [Related]
12. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin. Wu J; Jiang W; Shen Y; Jiang W; Tian R Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872 [TBL] [Abstract][Full Text] [Related]
14. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors. Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479 [TBL] [Abstract][Full Text] [Related]
17. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
18. Enhancing antibiofilm activity with functional chitosan nanoparticles targeting biofilm cells and biofilm matrix. Tan Y; Ma S; Leonhard M; Moser D; Haselmann GM; Wang J; Eder D; Schneider-Stickler B Carbohydr Polym; 2018 Nov; 200():35-42. PubMed ID: 30177175 [TBL] [Abstract][Full Text] [Related]
19. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050 [TBL] [Abstract][Full Text] [Related]
20. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]